Here are five key points:
1. NuVasive reported the insider selling transaction on Dec. 14, 2016, to the Securities and Exchange Commission.
2. The shares were valued at $67.99 per share.
3. In a SEC Form 4 Filing, NuVasive reported the sold shares’ total value was $700,501.
4. On Dec. 12, NuVasive shares saw an intraday low of $67.11 and intraday high of $68.55.
5. The company’s shares closed at $67.45 on Dec. 12.
More articles on devices:
Zimmer Biomet’s growth strategy in spine: MIS, cervical and becoming a ‘health solutions provider’
Predictive Technology Group highlights US patent allowance for treating patients with genetic spinal deformities, syndromes: 5 highlights
Global wearable medical devices market to hit $12.1B by 2021: 9 observations
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
